Meta Platforms enters its July 29 Q3 earnings preview in a materially different position than it held just a week ago: the stock has fallen roughly 8% in a single session following the Q2 report on July 22, closing Friday at $595.19, and the debate has shifted from whether the AI investment thesis would show up in numbers to whether Q3 guidance can justify a stock still trading well below analyst consensus.
The post-print selloff has done little to disturb the structural features of the options and lending markets. The put/call ratio has edged up to 0.47, about 1.7 standard deviations above its 20-day mean of 0.45 — the most defensively skewed reading in weeks, though still nowhere near the 52-week high of 0.79. That suggests modest incremental hedging after the drop rather than a wholesale repositioning. The borrow market remains frictionless: availability is effectively uncapped, with over 1.8 billion shares in the lending pool, and cost to borrow has held below 0.35%. Short interest, at 1.6% of the free float, is structurally thin and has moved barely at all — down fractionally on the week and up about 7% on the month in share terms, still the kind of level that generates no squeeze dynamics in either direction.
The analyst community has responded to the Q2 result by raising targets rather than retreating. Raymond James lifted to $850, Wells Fargo to $835, and Rothschild to $1,000 — all on July 21, the day before the report — locking in bullish conviction just as the stock was about to sell off 6%. The Street's mean target now sits at $826, implying roughly 39% upside to Friday's $595 close. That gap is the widest it has been across the recent reporting cycle, which cuts both ways: bulls argue the discount represents an entry point anchored by AI monetization and infrastructure scale; bears note that Meta's revenue model remains concentrated in data-driven advertising, vulnerable to both privacy regulation and cyclical ad-budget pressure. UBS trimmed its target from $865 to $766 earlier in the month without changing its Buy rating, while Citizens edged to $800 — a pattern of mild downgrades in conviction rather than wholesale exits.
The earnings history adds a relevant frame. The Q2 print produced a one-day decline of roughly 5.9%. The prior quarter's result on April 29 moved the stock down 8.9% on the day and a further 8.7% over five days. That is two consecutive double-digit post-earnings drawdowns from peaks, even against a backdrop of broadly bullish analyst positioning. The ORTEX short score has drifted only marginally lower in recent sessions, settling near 29.8, consistent with a stock where structured short pressure is absent and price moves are driven almost entirely by fundamental reaction to the numbers rather than positioning dynamics.
The July 29 print will test whether Q3 guidance — and the company's framing of AI capital expenditure returns — is strong enough to close even a fraction of the 39% gap between the current price and what the Street believes the stock is worth.
See the live data behind this article on ORTEX.
Open META on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
